Metraipolis › archive › dc_d428ab02108c

Evolution of the Use of Circulating DNA as a Biomarker in Neoadjuvant Therapy of Breast Cancer — Europe PMC PMID:42645355

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42645355
DOI
10.3390/curroncol33080450
License (as archived)
solo-consultazione
Archived
2026-10-17T15:17:22.234Z
SHA-256 of the archived text
4b12e9407b7c3277568ceaa0dde583d1936fd5b1f765d0972a11c1433f356e94
Stable URL of this page
https://metraipolis.com/documento/dc_d428ab02108c

How to cite

Evolution of the Use of Circulating DNA as a Biomarker in Neoadjuvant Therapy of Breast Cancer — Europe PMC PMID:42645355 — Europe PMC (en), https://europepmc.org/article/MED/42645355 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d428ab02108c (Metraipolis archive dc_d428ab02108c, sha256 4b12e9407b7c3277568ceaa0dde583d1936fd5b1f765d0972a11c1433f356e94)
BibTeX
@misc{dcd428ab02108c,
  title = {Evolution of the Use of Circulating DNA as a Biomarker in Neoadjuvant Therapy of Breast Cancer — Europe PMC PMID:42645355},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42645355},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d428ab02108c; sha256 4b12e9407b7c3277568ceaa0dde583d1936fd5b1f765d0972a11c1433f356e94},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42645355. Agents can read the archived copy with the MCP tool read_document.